EU Immunisation Campaigns
8 items
Sun, Apr 19, 2026
European Immunization Week 2026
European Immunization Week reminds citizens to get vaccinated for collective health protection.
Thu, Apr 23, 2026
European Immunization Week 2026 under way
EU promotes vaccination benefits for all ages during Immunization Week.
Tue, Apr 28, 2026
Europe steps up HPV vaccination for cancer prevention
Increased HPV vaccination rates boost cancer prevention efforts in Europe.
Thu, Apr 30, 2026
EMA Launches New Vaccine Confidence Group
EMA's new group tackles vaccine hesitancy to boost public trust in vital immunisation programs.
Sun, May 3, 2026
EMA Launches New Advisory Group on Vaccine Confidence
EMA tackles vaccine hesitancy to boost public health and trust in science.
Sun, May 3, 2026
EMA Launches Advisory Group on Vaccine Confidence
EMA tackles vaccine hesitancy to boost public health and trust.
Sat, May 9, 2026
EU issues 2026/2027 seasonal flu vaccine recommendations
EMA's flu vaccine recommendations ensure timely and effective public health protection for the upcoming season.
Tue, May 12, 2026
EU Recommendations for 2026/2027 Flu Vaccine
EU's EMA issues key recommendations for the 2026/2027 flu vaccine, protecting public health.
The European Union actively champions immunisation campaigns, with the European Centre for Disease Prevention and Control (ECDC) playing a central role. Right now, the EU is deeply engaged in European Immunization Week (EIW) 2026, a World Health Organization (WHO)-led initiative. This annual campaign reinforces the message that 'For every generation, vaccines work', stressing the lifelong benefits of vaccination and encouraging citizens to ensure their immunisations are current for collective health. A notable success comes from HPV vaccination efforts, with three countries already achieving the ambitious 90% target, significantly boosting Europe's cancer prevention agenda.
These initiatives profoundly matter for citizens and businesses alike. For individuals, robust vaccination programs like the intensified HPV vaccination directly prevent serious diseases such as cancer, safeguarding long-term health and reducing healthcare burdens. A healthy populace means fewer outbreaks, less absenteeism from work and school, and greater societal stability. For businesses, a healthier workforce contributes to increased productivity and resilience, mitigating economic disruptions often associated with widespread illness. Collective health protection fostered by immunisation underpins a thriving European economy.
Looking ahead, the EU's policy direction indicates a continued, intensified focus on increasing vaccination rates across all age groups. The success in HPV vaccination sets a precedent for achieving other immunisation targets, demonstrating the long-term effectiveness of sustained campaigns. The ongoing emphasis of EIW on collective health benefits and disease prevention signifies a commitment to protecting future generations from vaccine-preventable diseases. The ECDC will likely continue to monitor progress and coordinate efforts, driving Europe towards higher immunisation coverage and stronger public health resilience.